Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo

Gut

Volumn 44, Issue 3, 1999, Pages 366-371

  Ohashi, M ^a   Kanai, F ^a   Ueno, H ^b   Tanaka, T ^a   Tateishi, K ^a   Kawakami, T ^a   Koike, Y ^a   Ikenoue, T ^a   Shiratori, Y ^a   Hamada, H ^c   Omata, M ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c CANCER INSTITUTE   (Japan)

Author keywords

Adenovirus; Gastric cancer; Gene therapy; P53

Indexed keywords

DNA FRAGMENT; PROTEIN P53; VIRUS VECTOR;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

EID: 0032986051     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.3.366     Document Type: Article

References (22)

1. Wanebo HJ, Kennedy BJ, Chmiel J, et al. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993;218:583-92.
2. Thompson GB, van Heerden JA, Sarr MG. Adenocarcinoma of the stomach: are we making progress? Lancet 1993;342:713-18.
3. Weinberg RA. Tumor suppressor genes. Science 1991;254: 1138-46.
4. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
5. Tahara E, Semba S, Tahara H. Molecular biological observations in gastric cancer. Semin Oncol 1996;23:307-15.
6. Baker SJ, Markowitz S, Fearon ER, et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990;249:912-15.
7. Mercer WE, Shields MT, Amin M, et al. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 1990;87:6166-70.
8. Matozaki T, Sakamoto C, Suzuki T, et al. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Cancer Res 1992;52:4335-41.
9. Berkner KL. Expression of heterologous sequences in adenoviral vectors. Curr Top Microbiol Immunol 1992;158: 39-66.
10. Marcel T, Grausz JD. The TMC Worldwide Gene Therapy Enrollment Report, end 1996. Hum Gene Ther 1997;8: 775-800.
11. Miyake S, Makimura M, Kanegae Y, et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996;93: 1320-4.
12. Lan K-H, Kanai F, Shiratori Y, et al. Tumor-specific gene expression in carcinoembryonic antigen-producing gastric cancer cells using adenovirus vectors. Gastroenterology 1996;111:1241-51.
13. Kanai F, Lan K-H, Shiratori Y, et al. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res 1997;57:461-5.
14. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991;108:193-9.
15. Darzynkiewicz Z, Bruno S, Del Bino G, et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808.
16. Fujiwara T, Grimm EA, Mukhopadhyay T, et al. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 1994;54:2287-91.
17. Harris MP, Sutjipto S, Wills KN, et al. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Therapy 1996; 3:121-30.
18. Bookstein R, Demers W, Gregory R, et al. p53 gene therapy in vivo of herpatocellular and liver metastatic colorectal cancer. Semin Oncol 1996;23:66-77.
19. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80:293-9.
20. Hirschowitz EA, Ohwada A, Pascal WR, et al. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum Gene Ther 1995;6:1055-63.
21. Wills KN, Huang W-M, Harris MP, et al. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Therapy 1995;2:191-7.
22. Yanagihara K, Numoto M, Tauchi H, et al. Genetic status of p53 and induction of apoptosis by radiation or isoflavones in human gastric carcinoma cell lines. International Journal of Oncology 1996;9:95-102.